流通市值:8.84亿 | 总市值:12.81亿 | ||
流通股本:7657.18万 | 总股本:1.11亿 |
报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
流动资产: | ||||
货币资金 | 100,310,039.95 | 84,914,689.44 | 93,295,885.9 | 101,964,691.4 |
结算备付金 | 0 | 0 | 0 | 0 |
拆出资金 | 0 | 0 | 0 | 0 |
衍生金融资产 | 0 | 0 | 0 | 0 |
应收票据及应收账款 | 413,660,191.89 | 456,335,743.44 | 411,810,447.37 | 429,324,664.85 |
其中:应收票据 | 179,100,352.09 | 211,258,369.44 | 200,854,888.51 | 165,850,890.5 |
应收账款 | 234,559,839.8 | 245,077,374 | 210,955,558.86 | 263,473,774.35 |
应收款项融资 | 85,377,637.26 | 96,749,563.39 | 72,110,894.46 | 86,718,304.8 |
预付款项 | 66,761,591.24 | 41,086,780.87 | 42,073,289.33 | 32,752,478.52 |
应收保费 | 0 | 0 | 0 | 0 |
应收分保账款 | 0 | 0 | 0 | 0 |
应收分保合同准备金 | 0 | 0 | 0 | 0 |
其他应收款合计 | 5,391,968.9 | 4,752,553.42 | 5,700,064.26 | 6,097,203.98 |
其中:应收利息 | 0 | 0 | 0 | 0 |
应收股利 | 0 | 0 | 0 | 0 |
买入返售金融资产 | 0 | 0 | 0 | 0 |
存货 | 233,205,734.74 | 236,837,784.63 | 254,327,942.05 | 289,414,950.21 |
合同资产 | 0 | 0 | 0 | 0 |
一年内到期的非流动资产 | 0 | 0 | 0 | 0 |
其他流动资产 | 27,351,926.12 | 27,025,155.64 | 4,762,309.84 | 6,761,208.3 |
流动资产平衡项目 | 0 | 0 | 0 | 0 |
流动资产合计 | 932,059,090.1 | 947,702,270.83 | 884,080,833.21 | 953,033,502.06 |
非流动资产: | ||||
发放委托贷款及垫款 | 0 | 0 | 0 | 0 |
债权投资 | 0 | 0 | 0 | 0 |
其他债权投资 | 0 | 0 | 0 | 0 |
长期应收款 | 0 | 0 | 0 | 0 |
长期股权投资 | 0 | 0 | 0 | 0 |
其他权益工具投资 | 0 | 0 | 0 | 0 |
其他非流动金融资产 | 0 | 0 | 0 | 0 |
投资性房地产 | 11,031,558.41 | 11,280,989.71 | 11,529,021 | 11,778,452.3 |
固定资产 | 288,500,978.71 | 293,081,710.33 | 291,567,141.52 | 298,292,524.77 |
在建工程 | 17,429,061.68 | 12,702,631.18 | 13,372,508.59 | 5,284,179.69 |
生产性生物资产 | 0 | 0 | 0 | 0 |
油气资产 | 0 | 0 | 0 | 0 |
使用权资产 | 608,434.89 | 678,638.91 | 0 | 0 |
无形资产 | 40,749,219.68 | 40,909,932.36 | 41,281,164.15 | 41,657,285.91 |
开发支出 | 0 | 0 | 0 | 0 |
商誉 | 0 | 0 | 0 | 0 |
长期待摊费用 | 3,449,718.21 | 3,420,595.59 | 3,338,276.25 | 2,826,871.6 |
递延所得税资产 | 23,625,859.08 | 25,181,464.93 | 34,279,655.04 | 33,216,650.17 |
其他非流动资产 | 2,224,420 | 260,176.99 | 0 | 4,602,920 |
非流动资产平衡项目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 387,619,250.66 | 387,516,140 | 395,367,766.55 | 397,658,884.44 |
资产平衡项目 | 0 | 0 | 0 | 0 |
资产总计 | 1,319,678,340.76 | 1,335,218,410.83 | 1,279,448,599.76 | 1,350,692,386.5 |
流动负债: | ||||
短期借款 | 174,948,118.06 | 168,087,944.46 | 167,648,276.6 | 208,043,247.68 |
向中央银行借款 | 0 | 0 | 0 | 0 |
吸收存款及同业存放 | 0 | 0 | 0 | 0 |
拆入资金 | 0 | 0 | 0 | 0 |
交易性金融负债 | 0 | 0 | 0 | 0 |
衍生金融负债 | 0 | 0 | 0 | 0 |
应付票据及应付账款 | 204,630,054.31 | 251,412,078.36 | 217,938,027.85 | 246,208,347.84 |
其中:应付票据 | 53,662,928.8 | 83,614,496.46 | 99,061,356.09 | 98,408,446.03 |
应付账款 | 150,967,125.51 | 167,797,581.9 | 118,876,671.76 | 147,799,901.81 |
预收款项 | 0 | 0 | 0 | 0 |
合同负债 | 26,198,719.16 | 21,771,523.25 | 12,785,388.78 | 4,975,165.76 |
卖出回购金融资产款 | 0 | 0 | 0 | 0 |
应付手续费及佣金 | 0 | 0 | 0 | 0 |
应付职工薪酬 | 7,856,579.02 | 11,511,869.68 | 9,843,674.88 | 8,747,178.16 |
应交税费 | 3,351,018.54 | 3,738,658.78 | 6,280,738 | 6,787,688.57 |
其他应付款合计 | 2,143,817.61 | 2,123,252.76 | 5,581,207.61 | 2,267,331.79 |
其中:应付利息 | 0 | 0 | 0 | 0 |
应付股利 | 0 | 0 | 0 | 0 |
应付分保账款 | 0 | 0 | 0 | 0 |
保险合同准备金 | 0 | 0 | 0 | 0 |
代理买卖证券款 | 0 | 0 | 0 | 0 |
代理承销证券款 | 0 | 0 | 0 | 0 |
一年内到期的非流动负债 | 22,901,242.55 | 31,204,082.82 | 21,629,749.79 | 2,823,906.25 |
其他流动负债 | 160,632,759.48 | 146,671,133.07 | 131,071,087.59 | 147,514,023.96 |
流动负债平衡项目 | 0 | 0 | 0 | 0 |
流动负债合计 | 602,662,308.73 | 636,520,543.18 | 572,778,151.1 | 627,366,890.01 |
非流动负债: | ||||
长期借款 | 14,350,000 | 5,850,000 | 16,050,000 | 25,350,000 |
应付债券 | 0 | 0 | 0 | 0 |
优先股 | 0 | 0 | 0 | 0 |
永续债 | 0 | 0 | 0 | 0 |
租赁负债 | 315,833.63 | 315,833.63 | 0 | 0 |
长期应付款 | 0 | 0 | 0 | 0 |
长期应付职工薪酬 | 0 | 0 | 0 | 0 |
预计负债 | 6,774,866.36 | 6,751,522.05 | 6,931,222.22 | 6,772,123.6 |
递延收益 | 31,598,234.68 | 32,721,266.64 | 33,844,298.6 | 34,967,330.56 |
递延所得税负债 | 29,302.47 | 23,295.58 | 0 | 27,718.11 |
其他非流动负债 | 0 | 0 | 0 | 0 |
非流动负债平衡项目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 53,068,237.14 | 45,661,917.9 | 56,825,520.82 | 67,117,172.27 |
负债平衡项目 | 0 | 0 | 0 | 0 |
负债合计 | 655,730,545.87 | 682,182,461.08 | 629,603,671.92 | 694,484,062.28 |
所有者权益(或股东权益): | ||||
实收资本(或股本) | 110,970,000 | 110,970,000 | 110,970,000 | 110,970,000 |
其他权益工具 | 0 | 0 | 0 | 0 |
优先股 | 0 | 0 | 0 | 0 |
永续债 | 0 | 0 | 0 | 0 |
资本公积 | 291,386,983.72 | 291,386,983.72 | 291,386,983.72 | 291,386,983.72 |
减:库存股 | 0 | 0 | 0 | 0 |
其他综合收益 | 0 | 0 | 0 | 0 |
专项储备 | 0 | 0 | 0 | 0 |
盈余公积 | 29,016,069.05 | 29,016,069.05 | 28,019,815.61 | 28,019,815.61 |
一般风险准备 | 0 | 0 | 0 | 0 |
未分配利润 | 232,574,742.12 | 221,662,896.98 | 219,468,128.51 | 225,831,524.89 |
归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
归属于母公司股东权益合计 | 663,947,794.89 | 653,035,949.75 | 649,844,927.84 | 656,208,324.22 |
少数股东权益 | 0 | 0 | 0 | 0 |
股东权益平衡项目 | 0 | 0 | 0 | 0 |
股东权益合计 | 663,947,794.89 | 653,035,949.75 | 649,844,927.84 | 656,208,324.22 |
负债和股东权益合计 | 1,319,678,340.76 | 1,335,218,410.83 | 1,279,448,599.76 | 1,350,692,386.5 |
公告日期 | 2025-04-23 | 2025-04-23 | 2024-10-29 | 2024-08-22 |
审计意见(境内) | 标准无保留意见 |